{"id":"https://openalex.org/W7127581366","doi":"https://doi.org/10.3389/fmed.2025.1712586","title":"Efficacy of empagliflozin in patients with metabolic dysfunction-associated steatotic liver disease with or without diabetes: a systematic review and meta-analysis of randomized controlled trials","display_name":"Efficacy of empagliflozin in patients with metabolic dysfunction-associated steatotic liver disease with or without diabetes: a systematic review and meta-analysis of randomized controlled trials","publication_year":2026,"publication_date":"2026-02-04","ids":{"openalex":"https://openalex.org/W7127581366","doi":"https://doi.org/10.3389/fmed.2025.1712586","pmid":"https://pubmed.ncbi.nlm.nih.gov/41717349"},"language":"en","primary_location":{"id":"doi:10.3389/fmed.2025.1712586","doi":"https://doi.org/10.3389/fmed.2025.1712586","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmed.2025.1712586","pdf_url":"https://public-pages-files-2025.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1712586/pdf","source":{"id":"https://openalex.org/S2597052008","display_name":"Frontiers in Medicine","issn_l":"2296-858X","issn":["2296-858X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicine","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://public-pages-files-2025.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1712586/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Khalid I. AlHussaini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I240666556","display_name":"Imam Mohammad ibn Saud Islamic University","ror":"https://ror.org/05gxjyb39","country_code":"SA","type":"education","lineage":["https://openalex.org/I240666556"]}],"countries":["SA"],"is_corresponding":true,"raw_author_name":"Khalid I. AlHussaini","raw_affiliation_strings":["Department of Internal Medicine, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU)","institution_ids":["https://openalex.org/I240666556"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I240666556"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":2.2839,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.807096,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"12","issue":null,"first_page":"1712586","last_page":"1712586"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/non-alcoholic-fatty-liver-disease","display_name":"non-alcoholic fatty liver disease","score":0.9459999799728394},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8899999856948853},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9890000224113464},{"id":"https://openalex.org/keywords/hepatic-steatosis","display_name":"hepatic steatosis","score":0.7829999923706055},{"id":"https://openalex.org/keywords/liver-fibrosis","display_name":"liver fibrosis","score":0.9810000061988831},{"id":"https://openalex.org/keywords/alanine-aminotransferase","display_name":"alanine aminotransferase","score":0.9390000104904175},{"id":"https://openalex.org/keywords/aspartate-aminotransferase","display_name":"aspartate aminotransferase","score":0.972000002861023},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.8539999723434448},{"id":"https://openalex.org/keywords/controlled-attenuation-parameter","display_name":"controlled attenuation parameter","score":0.8019999861717224},{"id":"https://openalex.org/keywords/liver-stiffness-measurement","display_name":"liver stiffness measurement","score":0.9079999923706055},{"id":"https://openalex.org/keywords/apri","display_name":"APRI","score":0.6359999775886536},{"id":"https://openalex.org/keywords/fib-4-index","display_name":"FIB-4","score":0.8790000081062317},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8069999814033508},{"id":"https://openalex.org/keywords/lipid-parameters","display_name":"lipid parameters","score":0.41999998688697815},{"id":"https://openalex.org/keywords/non-alcoholic-steatohepatitis","display_name":"nonalcoholic steatohepatitis","score":0.8450000286102295},{"id":"https://openalex.org/keywords/noninvasive-fibrosis-markers","display_name":"non-invasive fibrosis markers","score":0.5709999799728394},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.4819999933242798},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.4779999852180481},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.5239999890327454}],"concepts":[{"id":"https://openalex.org/C2775887513","wikidata":"https://www.wikidata.org/wiki/Q5373824","display_name":"Empagliflozin","level":4,"score":0.9448999762535095},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9003000259399414},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.6352999806404114},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.632099986076355},{"id":"https://openalex.org/C2776175330","wikidata":"https://www.wikidata.org/wiki/Q1365091","display_name":"Steatosis","level":2,"score":0.6137999892234802},{"id":"https://openalex.org/C3020359197","wikidata":"https://www.wikidata.org/wiki/Q1359801","display_name":"Liver enzyme","level":2,"score":0.5629000067710876},{"id":"https://openalex.org/C2778772119","wikidata":"https://www.wikidata.org/wiki/Q6058862","display_name":"Fatty liver","level":3,"score":0.5288000106811523},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5059999823570251},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.48510000109672546},{"id":"https://openalex.org/C2777075537","wikidata":"https://www.wikidata.org/wiki/Q929737","display_name":"Liver disease","level":2,"score":0.4546999931335449},{"id":"https://openalex.org/C2992872382","wikidata":"https://www.wikidata.org/wiki/Q305481","display_name":"Alanine aminotransferase","level":2,"score":0.42320001125335693},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3873000144958496},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.34860000014305115},{"id":"https://openalex.org/C2776954865","wikidata":"https://www.wikidata.org/wiki/Q1546498","display_name":"Nonalcoholic fatty liver disease","level":4,"score":0.34619998931884766},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.3391999900341034},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3375999927520752},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3224000036716461},{"id":"https://openalex.org/C2909983478","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglycerides blood","level":4,"score":0.2971000075340271},{"id":"https://openalex.org/C2778606649","wikidata":"https://www.wikidata.org/wiki/Q305481","display_name":"Alanine transaminase","level":2,"score":0.2946000099182129},{"id":"https://openalex.org/C141341695","wikidata":"https://www.wikidata.org/wiki/Q2368661","display_name":"Surrogate endpoint","level":2,"score":0.2872999906539917},{"id":"https://openalex.org/C2908578062","wikidata":"https://www.wikidata.org/wiki/Q6058862","display_name":"Liver steatosis","level":4,"score":0.28610000014305115},{"id":"https://openalex.org/C2777693530","wikidata":"https://www.wikidata.org/wiki/Q6594689","display_name":"Benzhydryl compounds","level":4,"score":0.28060001134872437},{"id":"https://openalex.org/C2780578515","wikidata":"https://www.wikidata.org/wiki/Q657193","display_name":"Metabolic syndrome","level":3,"score":0.27559998631477356},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2685000002384186},{"id":"https://openalex.org/C2991848491","wikidata":"https://www.wikidata.org/wiki/Q2351083","display_name":"Metabolic disease","level":2,"score":0.26829999685287476},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2619999945163727},{"id":"https://openalex.org/C2910777643","wikidata":"https://www.wikidata.org/wiki/Q2448873","display_name":"Elevated liver enzymes","level":3,"score":0.2567000091075897}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fmed.2025.1712586","doi":"https://doi.org/10.3389/fmed.2025.1712586","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmed.2025.1712586","pdf_url":"https://public-pages-files-2025.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1712586/pdf","source":{"id":"https://openalex.org/S2597052008","display_name":"Frontiers in Medicine","issn_l":"2296-858X","issn":["2296-858X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicine","raw_type":"journal-article"},{"id":"pmid:41717349","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41717349","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in medicine","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:1c2b093fd3914e62824516b6953227c5","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/1c2b093fd3914e62824516b6953227c5","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Medicine, Vol 12 (2026)","raw_type":"article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12914734","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12914734/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Front Med (Lausanne)","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.3389/fmed.2025.1712586","doi":"https://doi.org/10.3389/fmed.2025.1712586","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmed.2025.1712586","pdf_url":"https://public-pages-files-2025.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1712586/pdf","source":{"id":"https://openalex.org/S2597052008","display_name":"Frontiers in Medicine","issn_l":"2296-858X","issn":["2296-858X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.5834389925003052,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320325415","display_name":"Al-Imam Muhammad Ibn Saud Islamic University","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7127581366.pdf","grobid_xml":"https://content.openalex.org/works/W7127581366.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W1491764483","https://openalex.org/W2000545769","https://openalex.org/W2009886169","https://openalex.org/W2093927266","https://openalex.org/W2107649622","https://openalex.org/W2128976060","https://openalex.org/W2136909828","https://openalex.org/W2341244791","https://openalex.org/W2520324928","https://openalex.org/W2561077285","https://openalex.org/W2737083386","https://openalex.org/W2742155329","https://openalex.org/W2759143872","https://openalex.org/W2808615577","https://openalex.org/W2810354499","https://openalex.org/W2890673765","https://openalex.org/W2914961474","https://openalex.org/W2970684805","https://openalex.org/W2973671909","https://openalex.org/W2999945678","https://openalex.org/W3084528742","https://openalex.org/W3088344065","https://openalex.org/W3106966221","https://openalex.org/W3118615836","https://openalex.org/W3130225195","https://openalex.org/W3186380763","https://openalex.org/W4213447109","https://openalex.org/W4309206837","https://openalex.org/W4318923555","https://openalex.org/W4380629916","https://openalex.org/W4391174490","https://openalex.org/W4391379346","https://openalex.org/W4393234810","https://openalex.org/W4399435116","https://openalex.org/W4401712318","https://openalex.org/W4403214520","https://openalex.org/W4407986499","https://openalex.org/W4409351940","https://openalex.org/W4409708224","https://openalex.org/W4413133795"],"related_works":[],"abstract_inverted_index":{"Background":[0],"Empagliflozin,":[1],"a":[2,277],"sodium-glucose":[3],"cotransporter-2":[4],"(SGLT2)":[5],"inhibitor,":[6],"has":[7],"demonstrated":[8],"potential":[9],"hepatic":[10,40,96,296],"benefits":[11],"in":[12,44,74,85,189,272,279,282,292,317],"patients":[13,45,76,283],"with":[14,24,46,77,269,284,304],"metabolic":[15,42],"dysfunction-associated":[16],"steatotic":[17],"liver":[18,86,106,273],"disease":[19],"(MASLD),":[20],"particularly":[21],"among":[22],"those":[23],"type":[25],"2":[26],"diabetes":[27],"mellitus":[28],"(T2DM).":[29],"This":[30],"meta-analysis":[31],"aimed":[32],"to":[33,63,66,112,162,175,181,198,309],"evaluate":[34],"the":[35,121],"efficacy":[36],"of":[37,53,58,295],"empagliflozin":[38,73,144],"on":[39],"and":[41,56,92,98,120,126,134,145,167,276,313],"outcomes":[43,82,128],"MASLD.":[47,285],"Methods":[48],"A":[49,183],"systematic":[50],"literature":[51],"search":[52],"PubMed,":[54],"Scopus,":[55],"Web":[57],"Science":[59],"was":[60,186,290],"conducted":[61],"up":[62],"September":[64],"2025":[65],"identify":[67],"randomized":[68],"controlled":[69,102],"trials":[70],"(RCTs)":[71],"evaluating":[72],"MASLD":[75,122,318],"or":[78,237,261,298],"without":[79],"T2DM.":[80],"Primary":[81],"included":[83,129],"changes":[84],"enzymes":[87],"including":[88,101],"alanine":[89],"aminotransferase":[90,94,111],"(ALT)":[91],"aspartate":[93,110],"(AST),":[95],"steatosis":[97,297],"fibrosis":[99,123],"indices":[100],"attenuation":[103],"parameter":[104],"(CAP),":[105],"stiffness":[107],"measurement":[108],"(LSM),":[109],"platelet":[113],"ratio":[114],"index":[115,118,256],"(APRI),":[116],"fibrosis-4":[117],"(FIB-4),":[119],"score":[124],"(NFS),":[125],"secondary":[127],"lipid":[130],"parameters,":[131],"glycemic":[132],"control,":[133],"anthropometric":[135],"measures.":[136],"Results":[137],"Eight":[138],"RCTs":[139,303],"involving":[140],"672":[141],"participants":[142],"(353":[143],"319":[146],"placebo)":[147],"were":[148,206,249],"included.":[149],"Empagliflozin":[150,266],"significantly":[151],"reduced":[152],"ALT":[153],"(mean":[154],"difference":[155],"[MD]":[156],"=":[157,165,170,178,193,201,211,214,218,221,225,228,232,235,240,243],"\u22129.36,":[158],"95%":[159,172,195],"CI:":[160,173,196],"\u221216.07":[161],"\u22122.66,":[163],"p":[164,177,200,213,220,227,234,242],"0.006)":[166],"AST":[168],"(MD":[169,192,210,217,224,231,239],"\u22129.09,":[171],"\u221215.41":[174],"\u22122.78,":[176],"0.005)":[179],"compared":[180],"placebo.":[182],"significant":[184,204,247,270],"reduction":[185,278],"also":[187],"observed":[188,250,291],"triglyceride":[190,280],"levels":[191,275,281],"\u221229.29,":[194],"\u221253.14":[197],"\u22125.45,":[199],"0.02).":[202],"No":[203],"differences":[205],"found":[207],"for":[208,251],"CAP":[209],"\u22125.72,":[212],"0.29),":[215],"LSM":[216],"\u22120.49,":[219],"0.38),":[222],"APRI":[223],"\u22120.02,":[226],"0.36),":[229],"FIB-4":[230],"\u22120.06,":[233],"0.34),":[236],"NFS":[238],"\u22120.04,":[241],"0.83).":[244],"Similarly,":[245],"no":[246,287],"effects":[248],"body":[252,254],"weight,":[253],"mass":[255],"(BMI),":[257],"fasting":[258],"blood":[259],"sugar,":[260],"glycated":[262],"hemoglobin":[263],"(HbA1c).":[264],"Conclusion":[265],"is":[267],"associated":[268],"improvements":[271],"enzyme":[274],"However,":[286],"clear":[288],"benefit":[289],"non-invasive":[293],"markers":[294],"fibrosis.":[299],"Further":[300],"large-scale,":[301],"long-duration":[302],"histological":[305],"endpoints":[306],"are":[307],"needed":[308],"confirm":[310],"these":[311],"findings":[312],"establish":[314],"empagliflozin\u2019s":[315],"role":[316],"management.":[319]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2026-02-06T00:00:00"}